Kymera Therapeutics, Inc.
Clinical trials sponsored by Kymera Therapeutics, Inc., explained in plain language.
-
New pill for eczema shows promise in early safety trial
Symptom relief CompletedThis early-stage study tested an oral medication called KT-621 in 22 adults with moderate to severe atopic dermatitis (eczema). The main goal was to check safety and how the body processes the drug. Researchers monitored side effects and drug levels in the blood, but did not meas…
Phase: PHASE1 • Sponsor: Kymera Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:15 UTC
-
Healthy volunteers test new drug KT-621 for safety
Knowledge-focused CompletedThis early-stage study tested the safety of an experimental oral drug called KT-621 in 118 healthy adults aged 19 to 55. Participants received either the drug or a placebo to check for side effects and how the drug moves through the body. The goal was not to treat any disease but…
Phase: PHASE1 • Sponsor: Kymera Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC